สัญลักษณ์ | YTM % | ปริมาณการซื้อขาย | ราคา % | ดอกเบี้ย % | วันครบกำหนดอายุ | ยอดคงค้าง | มูลค่าหน้าตั๋ว | จำนวนเงินขั้นต่ำ | ผู้ออก |
---|---|---|---|---|---|---|---|---|---|
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6.45% | 15 K | 86.00% | 5.25% | 2043-08-15 | 4.064 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
BMY.GCBristol-Myers Squibb Company 6.875% 01-AUG-2097 | 6.02% | 30 K | 119.38% | 6.88% | 2097-08-01 | 62.417 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 5.95% | 40 K | 87.86% | 5.00% | 2045-08-15 | 15.709 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5.92% | 290 K | 97.64% | 5.70% | 2040-10-15 | 2.299 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 5.89% | 100 K | 78.85% | 4.35% | 2047-11-15 | 13.567 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
US110122EC8BRIST.MYERS 23/63 | 5.74% | 0 | 112.17% | 6.40% | 2063-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 5.67% | 20 K | 84.30% | 4.55% | 2048-02-20 | 37.204 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
US110122EB0BRIST.MYERS 23/53 | 5.58% | 0 | 110.79% | 6.25% | 2053-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122EL8BRIST.MYERS 24/64 | 5.55% | 0 | 101.85% | 5.65% | 2064-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5009252Bristol-Myers Squibb Company 5.0% 15-AUG-2045 | 5.45% | 299 K | 94.09% | 5.00% | 2045-08-15 | 741.723 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122EK0BRIST.MYERS 24/54 | 5.44% | 0 | 101.77% | 5.55% | 2054-02-22 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5754772Bristol-Myers Squibb Company FRN 20-FEB-2026 | 5.40% | 284 K | 100.20% | 5.56% | 2026-02-20 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY.GNBristol-Myers Squibb Company 6.125% 01-MAY-2038 | 5.40% | 1.02 M | 107.15% | 6.13% | 2038-05-01 | 219.255 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5009251Bristol-Myers Squibb Company 4.35% 15-NOV-2047 | 5.40% | 490 K | 85.14% | 4.35% | 2047-11-15 | 1.236 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5007349Bristol-Myers Squibb Company 5.25% 15-AUG-2043 | 5.39% | 80 K | 98.24% | 5.25% | 2043-08-15 | 218.373 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 5.39% | 50 K | 90.21% | 4.63% | 2044-05-15 | 3.691 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
BMY5007348Bristol-Myers Squibb Company 5.7% 15-OCT-2040 | 5.37% | 298 K | 103.71% | 5.70% | 2040-10-15 | 151.011 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BRMGBRISTOL-MYERS 13/44 | 5.36% | 0 | 89.07% | 4.50% | 2044-03-01 | 341.52 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5009253Bristol-Myers Squibb Company 4.625% 15-MAY-2044 | 5.36% | 5.02 M | 90.60% | 4.63% | 2044-05-15 | 744.719 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122EJ3BRIST.MYERS 24/44 | 5.33% | 0 | 102.15% | 5.50% | 2044-02-22 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5009254Bristol-Myers Squibb Company 4.25% 26-OCT-2049 | 5.33% | 3.587 M | 83.82% | 4.25% | 2049-10-26 | 3.749 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY3883364Bristol-Myers Squibb Company 3.25% 01-AUG-2042 | 5.29% | 366 K | 75.38% | 3.25% | 2042-08-01 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5009250Bristol-Myers Squibb Company 4.55% 20-FEB-2048 | 5.27% | 937 K | 89.56% | 4.55% | 2048-02-20 | 1.235 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122DV7BRIST.MYERS 22/42 | 5.25% | 0 | 79.72% | 3.55% | 2042-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122DX3BRIST.MYERS 22/62 | 5.24% | 0 | 74.65% | 3.90% | 2062-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5007343Bristol-Myers Squibb Company 4.125% 15-JUN-2039 | 5.24% | 10.96 M | 88.24% | 4.13% | 2039-06-15 | 1.996 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122DW5BRIST.MYERS 22/52 | 5.23% | 0 | 75.60% | 3.70% | 2052-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122AP3BRISTOL-MYERS 2036 | 5.19% | 0 | 106.30% | 5.88% | 2036-11-15 | 279.22 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122DR6BRIST.MYERS 20/40 | 5.11% | 0 | 68.65% | 2.35% | 2040-11-13 | 750 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122DS4BRIST.MYERS 20/50 | 5.07% | 0 | 60.46% | 2.55% | 2050-11-13 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122DZ8BRIST.MYERS 23/33 | 5.04% | 0 | 106.33% | 5.90% | 2033-11-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 5.00% | 50 K | 95.66% | 3.45% | 2027-11-15 | 16.548 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
US110122EH7BRIST.MYERS 24/34 | 4.99% | 0 | 101.62% | 5.20% | 2034-02-22 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122DU9BRIST.MYERS 22/32 | 4.90% | 0 | 87.85% | 2.95% | 2032-03-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122DY1BRIST.MYERS 23/31 | 4.90% | 0 | 104.61% | 5.75% | 2031-02-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122EG9BRIST.MYERS 24/31 | 4.87% | 0 | 101.25% | 5.10% | 2031-02-22 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5007345Bristol-Myers Squibb Company 3.875% 15-AUG-2025 | 4.84% | 326 K | 99.06% | 3.88% | 2025-08-15 | 228.734 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5077466Bristol-Myers Squibb Company 0.75% 13-NOV-2025 | 4.83% | 13.461 M | 96.02% | 0.75% | 2025-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4.69% | 52 K | 97.60% | 3.90% | 2028-02-20 | 43.838 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
BMY5007342Bristol-Myers Squibb Company 3.4% 26-JUL-2029 | 4.69% | 4.969 M | 94.55% | 3.40% | 2029-07-26 | 2.373 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122ED6BRIST.MYERS 24/26 | 4.67% | 0 | 100.35% | 4.95% | 2026-02-20 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122EF1BRIST.MYERS 24/29 | 4.67% | 0 | 100.91% | 4.90% | 2029-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BRMJBRISTOL-MYERS 17/27 | 4.64% | 0 | 96.98% | 3.25% | 2027-02-27 | 512.277 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5077468Bristol-Myers Squibb Company 1.45% 13-NOV-2030 | 4.63% | 728 K | 83.23% | 1.45% | 2030-11-13 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122EE4BRIST.MYERS 24/27 | 4.60% | 0 | 100.64% | 4.90% | 2027-02-22 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5007347Bristol-Myers Squibb Company 3.9% 20-FEB-2028 | 4.58% | 205 K | 97.93% | 3.90% | 2028-02-20 | 1.45 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY5007341Bristol-Myers Squibb Company 3.2% 15-JUN-2026 | 4.56% | 7.717 M | 97.91% | 3.20% | 2026-06-15 | 1.744 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
US110122DP0BRIST.MYERS 20/27 | 4.55% | 0 | 90.38% | 1.13% | 2027-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY.GBBristol-Myers Squibb Company 6.8% 15-NOV-2026 | 4.52% | 70 K | 104.38% | 6.80% | 2026-11-15 | 255.948 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. |
BMY5007346Bristol-Myers Squibb Company 3.45% 15-NOV-2027 | 4.45% | 295 K | 97.19% | 3.45% | 2027-11-15 | 517.675 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
XS122674851BRISTOL-MYERS 15/35 | 3.13% | 0 | 87.52% | 1.75% | 2035-05-15 | 575 M EUR | 1,000.00 EUR | 100,000.00 EUR | Bristol Myers Squibb Co. |
BMY4831828Bristol-Myers Squibb Company 4.25% 26-OCT-2049 | 2.64% | 0 | 130.24% | 4.25% | 2049-10-26 | 500 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY4933148Bristol-Myers Squibb Company 5.0% 15-AUG-2045 | 2.47% | 0 | 141.76% | 5.00% | 2045-08-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY4931963Bristol-Myers Squibb Company 4.55% 20-FEB-2048 | 2.47% | 0 | 137.60% | 4.55% | 2048-02-20 | 9.5 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY4831826Bristol-Myers Squibb Company 4.125% 15-JUN-2039 | 2.30% | 0 | 122.76% | 4.13% | 2039-06-15 | 4.4 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BRMHBRISTOL-MYERS 15/25 | 1.95% | 0 | 99.06% | 1.00% | 2025-05-15 | 575 M EUR | 1,000.00 EUR | 100,000.00 EUR | Bristol Myers Squibb Co. |
BMY4831822Bristol-Myers Squibb Company 3.2% 15-JUN-2026 | 0.51% | 0 | 104.25% | 3.20% | 2026-06-15 | 5.953 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY4831824Bristol-Myers Squibb Company 3.4% 26-JUL-2029 | −0.14% | 0 | 116.69% | 3.40% | 2029-07-26 | 26.556 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY4945645Bristol-Myers Squibb Company 3.9% 20-FEB-2028 | −1.14% | 0 | 116.80% | 3.90% | 2028-02-20 | 6.07 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |
BMY4926518Bristol-Myers Squibb Company 3.45% 15-NOV-2027 | −1.36% | 0 | 114.77% | 3.45% | 2027-11-15 | 67 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |